Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Randomized trials in vulnerable populations.

Deborah Cook1, Anne Moore-Cox, Denis Xavier

  • 1Department of Medicine, McMaster University Health Sciences Center, Hamilton, Ontario, Canada. debcook@mcmaster.ca

Clinical Trials (London, England)
|February 20, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pantoprazole Use in Invasively Ventilated Patients With Septic Shock: A Protocol and Statistical Analysis Plan.

Acta anaesthesiologica Scandinavica·2026
Same author

Correction: How would Marie Kondo design a protocol? In favor of subtractive change in clinical trials.

Frontiers in medicine·2026
Same author

How would Marie Kondo design a protocol? In favor of subtractive change in clinical trials.

Frontiers in medicine·2026
Same author

Considerations for environmental sustainability in clinical trials: A case study simulation of the REVISE trial.

Journal of critical care·2026
Same author

Coenrollment of critically ill patients in PROSPECT: A protocol and statistical analysis plan.

PloS one·2026
Same author

A survey of stress ulcer prophylaxis practice patterns for critically ill patients before and after participating in a randomised controlled trial.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2026
Same journal

A statistical evaluation of decision-making methods and the efficiency of Bayesian multi-arm multi-stage trials.

Clinical trials (London, England)·2026
Same journal

Accounting for non-adherence: A re-analysis of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial.

Clinical trials (London, England)·2026
Same journal

Phase I design for partially ordered groups with late-onset toxicity.

Clinical trials (London, England)·2026
Same journal

Trial informed consent forms, the Declaration of Helsinki and the SPIRIT 2025 statement.

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Morning panel discussion).

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Afternoon panel discussion).

Clinical trials (London, England)·2026
See all related articles

Conducting clinical trials with vulnerable populations is crucial for medical advancement. This study outlines six key challenges and proposes collaborative solutions to enhance trial safety and relevance for all participants.

Area of Science:

  • Clinical Research Ethics
  • Vulnerable Populations in Research
  • Regulatory Science

Background:

  • Clinical trials involving vulnerable populations present unique ethical considerations due to potential diminished autonomy.
  • Despite these challenges, such research is essential for determining effective medical interventions and ensuring patient safety.

Purpose of the Study:

  • To identify specific challenges in conducting randomized clinical trials in vulnerable populations.
  • To propose actionable solutions for overcoming these identified challenges.
  • To emphasize the need for global collaboration among all stakeholders.

Main Methods:

  • Identification of six key challenges in vulnerable population clinical trials.
  • Analysis of macro issues including scope, funding, and investigator capacity.

Related Experiment Videos

  • Examination of research ethics review, informed consent, regulatory hurdles, and adverse event reporting.

    • Main Results:

    • Six distinct challenges in clinical trials for vulnerable groups were identified.
    • Potential solutions were proposed for each challenge, addressing both macro and micro issues.
    • The importance of stakeholder awareness and collaboration was highlighted.

    Conclusions:

    • Addressing challenges in vulnerable population trials requires a multi-faceted, collaborative approach.
    • Improved quality, quantity, safety, and relevance of trials for vulnerable persons globally is achievable.
    • Continuous engagement from all stakeholders is vital for ethical and effective clinical research.